Treatment Bridging With a 28-Day Metronomic Therapy (Metro-28) for Relapsed Refractory Multiple Myeloma

Clin Lymphoma Myeloma Leuk. 2021 Sep 11:S2152-2650(21)02033-4. doi: 10.1016/j.clml.2021.09.004. Online ahead of print.NO ABSTRACTPMID:34670732 | DOI:10.1016/j.clml.2021.09.004
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research